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Zeta Inhibitory Peptide attenuates learning and
memory by inducing NO-mediated downregulation
of AMPA receptors
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Zeta inhibitory peptide (ZIP), a PKMζ inhibitor, is widely used to interfere with the main-
tenance of acquired memories. ZIP is able to erase memory even in the absence of PKMζ, via
an unknown mechanism. We found that ZIP induces redistribution of the AMPARGluA1 in
HEK293 cells and primary cortical neurons, and decreases AMPAR-mediated currents in the
nucleus accumbens (NAc). These effects were mimicked by free arginine or by a modified
ZIP in which all but the arginine residues were replaced by alanine. Redistribution was
blocked by a peptidase-resistant version of ZIP and by treatment with the nitric oxide (NO)-
synthase inhibitor L-NAME. ZIP increased GluA1-S831 phosphorylation and ZIP-induced
redistribution was blocked by nitrosyl-mutant GluA1-C875S or serine-mutant GluA1-S831A.
Introducing the cleavable arginine-alanine peptide into the NAc attenuated expression of
cocaine-conditioned reward. Together, these results suggest that ZIP may act as an arginine
donor, facilitating NO-dependent downregulation of AMPARs, thereby attenuating learning
and memory.
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Long-term potentiation (LTP) is the leading cellularmechanism of learning and memory, and sustained activa-tion of protein kinase M Zeta (PKMζ) is essential for its
maintenance1. This concept mostly relies on the ability of Zeta
Inhibitory Peptide (ZIP), originally synthesized as a pseudo-
substrate inhibitor of PKMζ2–4, to interfere with LTP and erase
memory in a variety of learning tasks including spatial sensiti-
zation5, pain sensitization6, fear-associated memories7, condi-
tioned taste aversion8 and development of locomotor
sensitization in rodents9. Remarkably, however, two parallel
studies generating transgenic mice lacking PKMζ found no
impairments in learning and memory10,11. More surprisingly,
application of ZIP or its scrambled PKMζ-inactive form (scrZIP)
to hippocampal slices of the PKMζ knockout mice, abolished an
established LTP11. It seems, therefore, that PKMζ is not required
for LTP or for learning and memory, and that the effects of ZIP
(and scrZIP) on these parameters must occur independently of
PKMζ inhibition. The mechanism of ZIP action remains an open
puzzling question.
Previously, we showed that microinjection of ZIP into the
nucleus accumbens (NAc), a key structure within the reward
system, abolished cocaine-conditioned reward12, as also shown
subsequently in PKMζ knockout mice10. In the current study, we
examine the hypothesis that ionotropic glutamate AMPA recep-
tors (AMPARs) may be a target of the action of ZIP. Therefore,
we characterized the effect of ZIP on AMPARs using hetero-
logous expression in HEK293 cells and primary cortical neurons,
and electrophysiological recordings from NAc slices as well as
behavioral studies.
Our findings suggest a molecular mechanism in which
membrane-bound myristoylated ZIP may act as an arginine
donor, thereby inducing nitrosylation-mediated endocytosis of
AMPARs. Subsequent downregulation of AMPARs activity
results in attenuation of cocaine-conditioned reward.
Results
ZIP induces GluA1 redistribution in HEK293 cells and neu-
rons. Since it was well established that ZIP reduces EPSCs in CA1
hippocampal neurons together with its ability to erase established
memories in PKMζ knockout mice10,11, we hypothesized that ZIP
functionally interacts with AMPARs. To test this hypothesis, we
transfected HEK293 cells with different AMPAR GFP-tagged
subunits and visualized them with confocal fluorescence micro-
scopy. When transfected HEK293 cells were exposed to ZIP
(5 μM), we observed a time-dependent redistribution of GluA1
through the cell body (Fig. 1a, b). Similar results were observed
with scrZIP (5 μM), but not with vehicle (PBS). This effect was
AMPAR-subunit specific since bath application of ZIP or scrZIP
to HEK293 expressing GFP-GluA2 had no effect on the dis-
tribution (Fig. 1c). To confirm that this observation was inde-
pendent of PKMζ, we tested its expression in HEK293 cell
homogenates in comparison with brain homogenates. Although
PKCζ was present, we found that HEK293 cells did not express
PKMζ (although both are expressed in the brain; Fig. 1d), con-
firming our hypothesis that the action of ZIP is independent of
PKMζ. We also confirmed the absence of PKCι/λ, another
reported target of ZIP13, in HEK293 lysates, ruling out its
involvement (Fig. 1d). Finally, to investigate whether PKCζ itself
was involved in ZIP-mediated GluA1 redistribution, we treated
GFP-tagged GluA1-expressing cells with ZIP (5 μM) or vehicle
for 40 min and tested for the presence of the Thr410-
phosphorylated (activated) PKCζ14 we found no change in
PKCζ phosphorylation state (Fig. 1d).
To analyze ZIP-mediated effects on endogenous AMPARs, we
prepared primary cortical neurons, incubated with ZIP and
stained with antibodies recognizing the extracellular domain of
GluA1, therefore detecting only surface receptors15. As shown in
Fig. 1e, the fluorescent signal of GluA1 decreased significantly
following ZIP treatment. Together, these data suggest that in
HEK293 cells and in neurons, ZIP induces redistribution of
GluA1 to inner cell compartments and that this action is
independent of PKMζ.
ZIP causes a decrease in AMPAR-EPSCs in the NAc. Next, we
examined whether ZIP-mediated GluA1 redistribution has
functional consequences on AMPARs in the brain. We focused
on the NAc, since in our previous work we demonstrated the
ability of ZIP to interfere with cocaine-conditioned reward in this
area12. AMPAR-EPSCs in NAc slices of naïve rats were markedly
depressed (~50%) following application of ZIP (5 µM; Fig. 1f).
The effect of ZIP started ~20 min post application, a delay also
observed previously11. We obtained similar results with the
application of scrZIP (Fig. 1f). Since previous studies suggested
that ZIP might affect the viability of the neurons or synaptic
membrane integrity16, thereby causing the apparent reduction in
AMPAR EPSCs, we tested the resting membrane potential in the
presence of ZIP (Fig. 1g). We observed a stable potential value
that started to gradually decline only after 50 min. This indicates
that the reduction in AMPAR-EPSCs in the presence of ZIP is not
due to cell toxicity (at least not during the first 50 min).
ZIP/scrZIP act as arginine donors and decrease AMPAR-
EPSCs. As both ZIP and scrZIP elicited similar effects on
recombinant and native AMPARs, it appeared that the amino
acids of the peptides themselves were responsible for these effects.
Of its 13 amino acids, ZIP contains five arginine residues
(Fig. 2a). Arginine is a known substrate of nitric oxide synthase
(NOS) which produces nitric oxide (NO), and NO-mediated S-
nitrosylation of GluA1 was shown to promote AMPARs endo-
cytosis17. We therefore hypothesized that cleavage of ZIP by cell
peptidases would release free arginine residues, resulting in
upregulation of NO production, removal of AMPARs from the
cell membrane and thus loss of function. To begin to test this
hypothesis, we examined the effect of free arginine on AMPAR-
EPSCs. Bath application of L-Arg (25 μM) decreased AMPAR-
EPSCs in NAc slices (Fig. 2b), similar to ZIP (Fig. 1f). Next, to
investigate whether the free arginine residues were indeed origi-
nating from the cleavage of ZIP, we designed two peptides: (1)
peptide B, having all, but the five ZIP arginine residues replaced
with alanine, and (2) peptide C, having the five ZIP arginine
residues, but with the peptidase-cleavage sites removed by
appropriate amino acid replacements (Fig. 2c). We then tested the
ability of these two new peptides to alter AMPAR-EPSCs in NAc
slices. As shown in Fig. 2c (right), the arginine–alanine peptide B
(5 μM) inhibited AMPAR-EPSCs to the same extent as ZIP
(Fig. 1f) and caused a similar redistribution of GluA1 in HEK293
cells (Fig. 2d). In contrast, the peptidase-resistant peptide C (5
μM), had no effect on AMPAR-EPSCs or on GluA1 localization
in HEK293 cells (Fig. 2d). These results suggest that increased
levels of free arginine residues, originating from the cleavage of
ZIP, mediate the effects of ZIP seen in HEK293 cells and in the
NAc.
Membrane-localized ZIP activates NOS. Due to the presence of
the myristoyl group within the peptide, we hypothesized that ZIP
localized to the cell membrane. To test its localization, we tagged
ZIP with the fluorescence marker FITC positioned immediately
after the myristoyl group (FITC-ZIP). We first confirmed that
FITC-ZIP does not induce excitotoxic cell death by performing
in vivo microinjections of peptide or vehicle into the NAc. Brain
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slices from the injected regions prepared 6, 12, and 24 h after the
injection, showed that both FITC-ZIP and vehicle injections
caused tissue damage during penetration, but without a sig-
nificant decrease in cell number compared to non-injected ani-
mals (Fig. 3a, 24 h post injection). In order to verify that the
addition of FITC did not impair ZIP activity, we tested its effect
on sustained LTP induced in NAc slices as previously shown for
ZIP in the CA111. We first induced LTP by high frequency sti-
mulation (HFS) and following the establishment of LTP we bath
applied FITC-ZIP (5 μM). Similar to ZIP11, FITC-ZIP inhibited
the increase of fEPSPs (Fig. 3b).
Next, we incubated FITC-ZIP with HEK293 cells or with
primary cortical neurons for 1 h and observed that FITC-ZIP
localized to the cell membrane in both cell types (Fig. 3c, top). We
hypothesized that once ZIP enters the cell, it will be cleaved by
peptidases, resulting in an increased level of free arginine within
the cell. To test this hypothesis, we prepared a peptide in which
the FITC group was added with a linker between the last two
amino acids of ZIP (ZIP-FITC). If ZIP is cleaved within the cell,
we than expected the FITC signal to spread throughout the cell.
While FITC-ZIP was localized at the membrane, the ZIP-FITC
signal was spread throughout the cell in both HEK293 cells and in
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Fig. 1 ZIP causes redistribution of GluA1 in HEK293 cells and primary cortical neurons and decreases AMPAR-EPSCs in NAc neurons. a–c ZIP scrZIP
(5 µM), or vehicle (PBS) were bath applied to HEK293 cells expressing GFP-GluA1 (a, b) or GFP-GluA2 (c). a Live cells were imaged using fluorescent
confocal microscopy and representative fluorescent images are shown at time points during the incubation, as indicated: (GluA1: ZIP n= 12, scrZIP n= 7,
PBS n= 3; GluA2: ZIP n= 5, scrZIP n= 2). b GluA1-expressing cells were fixed after 40min of incubation with ZIP or vehicle, and the fluorescence was
visualized. Graph depicts line scan of GFP signal intensity across the cell. Data expressed as mean ± SEM, arbitrary units (A.U.) with n= 12 for ZIP (green),
n= 10 for scrZIP (blue), n= 7 for vehicle (white). Data analyzed by one-way ANOVA (F= 13.27, p < 0.0001) followed by Tukey post hoc test for multiple
comparisons, where vehicle vs. ZIP *p < 0.0001, vehicle vs. scrZIP, #p= 0.0022). c GluA2-expressing cells were live monitored as in (a) (GluA2: ZIP n= 5,
scrZIP n= 2). d Western blots of HEK293 cell homogenates containing GFP-GluA1 treated with ZIP (5 µM) or vehicle (PBS) and stained with antibodies
against activated PKCζ (p-PKCζ) and total PKCζ. Graph depicts the levels of p-PKMζ normalized to total PKMζ ± SEM. Two-tailed unpaired t test
revealed no significant difference (p= 0.7722, n= 3 for each group). e ZIP (5 μM) or vehicle (PBS) were bath applied to primary cortical neurons (DIV7)
for 40min. Membrane expression of AMPARs was visualized (left) and quantified with extracellular GluA1 AMPAR antibody (ZIP n= 10, vehicle n= 10;
*p < 0.0001, two-tailed t test, data expressed as mean ± SEM). f AMPAR-EPSCs from NAc slices evoked by afferent stimulation recorded at holding
potential of −70mV, before and after bath application of ZIP (5 μM) (green; N= 7, n= 7), scrambled ZIP (5 μM) (blue; N= 5, n= 7) or vehicle (white;
N= 7, n= 7). Representative EPSC traces taken at the time points indicated by asterisks are shown above. Data presented using normalized values ± SEM.
gMeasurements of membrane resting potential of NAc medium spiny GABAergic neurons following bath application of ZIP or vehicle using current–clamp
mode (N= 5, n= 5). Data presented using normalized values ± SEM.
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Fig. 2 ZIP mediates its effects on recombinant and native AMPARs by serving as an arginine donor. a Peptide structures of ZIP and scr-ZIP. Arginine
residues are marked in red. scrZIP contains the ZIP amino acids in a random order. b AMPAR-EPSCs, recorded before and after bath application of L-Arg
(5 μM, N= 4, n= 4). Data presented using normalized values ± SEM. c Peptide B but not peptide C mimics ZIP effects. Peptide B contains the five arginine
residues of ZIP, replacing the eight other amino acids with alanine. Peptide C also contains five arginine residues but lacks its peptidase-cleavage sites due
to appropriate replacements (see structures and sequences). Right, AMPAR-EPSCs recorded before and after application of peptide B (N= 3, n= 4) or
peptide C (N= 3, n= 3). Data presented using normalized values ± SEM. d Representative fluorescent images of fixed GFP-GluA1-expressing HEK293
cells, incubated for 40min prior to the fixation with one of the peptides or vehicle. Graph depicts line scan of GFP signal intensity mean ± SEM (vehicle n=
7, Peptide B n= 10, Peptide C n= 9; F= 23.85, p < 0.0001, one-way ANOVA, followed by Tukey post hoc test for multiple comparisons, Peptide B vs.
vehicle ***p < 0.0001, Peptide B vs. Peptide C ***p < 0.0001).
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Fig. 3 ZIP is localized to the membrane in both HEK293 cells and primary cortical neurons. a Assessment of brain cell viability. FITC-ZIP (green, 1 mM)
or vehicle were microinjected into the NAc of rats (AP+ 1.75, ML ± 1.48, DV −6.2). Twenty-four hour after injection, animals were sacrificed and brain
slices containing the NAc were stained with NeuN (red) or DAPI (blue). Graph depicts the number of DAPI-stained cells mean ± SEM in non-injected (N=
5), vehicle injected (N= 5) and FITC-ZIP injected (N= 11) brains. No significant difference was observed between groups (F= 2.912, p= 0.0802, one-way
ANOVA; naïve vs. vehicle p= 0.4740, Naïve vs. FITC-ZIP p= 0.0675, vehicle vs. FITC-ZIP p= 0.5843). bMeasurements of FITC-ZIP activity and cellular-
membrane localization. fEPSPs in NAc slices were monitored before and after high frequency stimulation (HFS; arrow) to induce LTP. FITC-ZIP (5 µM)
(green circles; N= 3, n= 4) or vehicle (white circles; N= 3, n= 3) were bath applied 10min following application of HFS. Data presented using normalized
values ± SEM. c Representative fluorescent images visualized with confocal microscopy taken from HEK293 cells (left) or mouse embryonic primary
cortical neurons (right; DIV7) incubated with FITC-ZIP (5 µM, top; HEK293 N= 5, Neurons N= 5) or ZIP-FITC (5 µM, bottom; HEK293 N= 4, Neurons
N= 5) for 1 h. d HEK293 cells were incubated with ZIP-FITC (5 µM) for the time indicated in the panel. Fluorescence was visualized with a confocal
microscope. Graph depicts line scan of FITC signal intensity mean ± SEM (1 min, n= 13; 5 min, n= 12; 10 min, n= 11; 15 min, n= 12; F= 32.16,
p < 0.0001, one-way ANOVA, followed by Tukey post hoc test for multiple comparisons, zero point vs. 5 min. ***p < 0.0001, zero point vs. 10 min.
***p < 0.0001, zero point vs. 15 min. ***p < 0.0001).
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primary cortical neurons (Fig. 3c, bottom). If ZIP acts to
stimulate NOS through provision of its substrate L-arginine, ZIP
should be rapidly proteolyzed. We therefore treated HEK cells
with ZIP-FITC and imaged fluorescence over a short-time period
(Fig. 3d). As soon as 5 min after application, the fluorescent signal
was spread throughout the cell. Taken together, these results
indicate that ZIP undergo a rapid cleavage and strengthens our
hypothesis that ZIP acts locally to affect NOS and AMPARs.
NO inhibition blocks ZIP-mediated effects in HEK293 and
NAc. Since we observed that ZIP could serve as an arginine
donor, a known substrate of NOS, we next tested the ability of the
NOS inhibitor L-NAME to attenuate ZIP-mediated effects on
recombinant GluA1 and native AMPARs. Application of L-
NAME together with ZIP inhibited the redistribution of GluA1 in
HEK293 cells (Fig. 4a) and completely prevented the reduction of
AMPAR-EPSCs by ZIP in NAc slices (Fig. 4b). To confirm that
the mechanism of action was indeed through ZIP-donated argi-
nine, we repeated these experiments with the arginine–alanine
peptide B. L-NAME prevented both GluA1 redistribution in
HEK293 cells (Fig. 4c) and the reduction of AMPAR-EPSCs
by peptide B in NAc slices (Fig. 4d), mirroring the effects elicited
by ZIP.
Taken together, these results suggest that cleavage of
membrane-bound ZIP produces high levels of free arginine
residues which activate NOS to produce NO leading, in turn, to
the cellular redistribution of GluA1 and reduction of AMPAR-
EPSCs.
ZIP induces S-nitrosylation and phosphorylation of GluA1.
S-nitrosylation of GluA1 at C875 enhances S831 phosphorylation,
facilitates the associated increase in AMPAR conductance and
results in AMPAR endocytosis by increasing receptor binding to
the AP2 protein of the endocytic machinery17. Therefore, we
tested whether the ZIP-induced redistribution of GluA1 is
mediated via the same signaling pathway, by using a mutant
GluA1 in which the cysteine on position 875 was exchanged
to serine (GluA1-C875S)17. In contrast to wild-type GluA1,
application of ZIP or the cleavable arginine-alanine peptide B to
HEK293 cells expressing the GluA1-C875S mutant did not
affect receptor localization (Fig. 5a, middle row), suggesting that
ZIP-mediated AMPAR redistribution requires nitrosylation of
GluA1.
As nitrosylation of GluA1 leads to phosphorylation of GluA1-
S83117, we next tested whether ZIP affects the phosphorylation
state of GluA1-S831 in NAc neurons. We found that bath
application of ZIP or scrZIP (5 μM, 1 h) to NAc-containing brain
slices, enhanced GluA1-S831 phosphorylation compared with
vehicle-treated slices (Fig. 5b). Given the increased phosphoryla-
tion observed following ZIP application, we therefore predicted
that mutation of GluA1 S831 will also result in blocking ZIP-
induced GluA1 redistribution. We therefore repeated the
experiment with ZIP and peptide B using HEK293 cells
expressing a non-phosphorylatable GluA1-S831A mutant. Both
peptides failed to cause the redistribution of the mutated GluA1
into the cell (Fig. 5a, bottom row). Together, these results strongly
suggest that nitrosylation followed by phosphorylation of GluA1
are required for GluA1 redistribution and provide the linkage
between nitrosylation and phosphorylation. Altogether, these
results support the possibility that ZIP reduces AMPAR-mediated
currents through S-nitrosylation and GluA1 phosphorylation that
promotes AMPAR endocytosis.
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Fig. 4 ZIP-induced GluA1 redistribution in HEK293 cells and AMPAR-EPSCs decrease in the NAc are mediated by NO. a Representative fluorescent
images taken from continuous live monitoring of HEK293 cells expressing GFP-GluA1, at 1 and 30min after bath application of ZIP (5 µM), without (left
panels, N= 5) or with L-NAME (50 µM, right panels, N= 5). b AMPAR-EPSCs before and after application of ZIP without (green circles; N= 7, n= 7) or
with L-NAME (light blue circles; N= 7 n= 7). Representative EPSC traces taken at the time indicated by the asterisks are shown on the top. Data
presented using normalized values ± SEM. c Representative fluorescent images taken from HEK293 cells expressing GFP-GluA1 fixed after 40min
incubation with ZIP (5 μM, left; N= 5), Peptide B (5 μM, middle; N= 6) and Peptide B (5 μM) + L-NAME (50 μM, right; N= 5). d AMPAR-EPSCs recorded
before and after application of Peptide B in the presence (light blue circles; N= 5, n= 5) or absence of L-NAME (orange circles; N= 5 n= 5). Data
presented using normalized values ± SEM.
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ZIP, scrZIP, or peptide B decrease the expression of CPP. We
previously reported that microinjection of ZIP into the NAc
following conditioning to cocaine abolished the expression of
CPP12. If the action of ZIP is indeed mediated via an increase in
free arginine residues, we predicted that the arginine–alanine
peptide B or scrambled ZIP would similarly affect cocaine CPP. A
day after the completion of the conditioning paradigm, rats were
microinjected with peptide B or scrambled ZIP into the NAc and
after 24 h, they were tested for their preference. Rats receiving
either peptide showed a significant reduction in the expression of
CPP compared with vehicle-injected animals (Fig. 5c). However,
the non-cleavable peptide C, which did not alter GluA1 redis-
tribution or AMPAR-mediated currents in the NAc, had no effect
on cocaine CPP (Fig. 5c). These results strongly suggest that the
action of ZIP in attenuating cocaine-conditioned reward are
mediated by changes in the levels of free arginine in the synapses
of NAc neurons.
Together, our findings suggest a molecular mechanism for the
action of ZIP. Myristoylated ZIP localizes to the cell membrane
and is cleaved by peptidases to produce free arginine residues.
Free arginine induces the production of NO by activation of NOS.
NO, in turn, nitrosylates (SNO) cysteine 875 on the cytoplasmic
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tail of AMPAR GluA1, which induces phosphorylation (P) of
GluA1 on serine 831, leading to endocytosis of the GluA1-
containing AMPARs and their downregulation (Fig. 6).
Discussion
Although ZIP has its origin as a pseudo-substrate of PKMζ, recent
studies in PKMζ knock-out mice have confirmed that we do not
yet completely understand its mechanism of action. Here, we
used HEK293 cells expressing GluA1, primary cortical neurons
and electrophysiology in NAc slices to examine the hypothesis
that ZIP acts as a regulator of GluA1 activity, independent of
PKMζ. We found that ZIP serves as a source of free arginine
residues that activate NOS to produce NO, causing nitrosylation
of GluA1 and eventually its endocytosis and downregulation.
While these results contradict many studies implicating ZIP as a
PKMζ inhibitor1, our data are in line with previous work sug-
gesting that ZIP can act independently of PKMζ to interfere with
synaptic plasticity and long-term memory18,19. To this end, we
tested the ability of ZIP to affect one of the key players in LTP, the
AMPARs. Although we have no evidence to show a physical
interaction of ZIP with GluA1, our results indicate that ZIP
interferes with the normal function of AMPARs. In HEK293 cells
expressing GluA1 in the absence of PKMζ, ZIP causes redis-
tribution of GluA1, suggesting that ZIP functionally interacts
with GluA1, independent of PKMζ. Therefore, we hypothesized
that the ZIP-induced inhibition of AMPAR-EPSCs in the brain is
due to its ability to downregulate the AMPAR activity. Indeed,
our findings demonstrate that ZIP decreases AMPAR-EPSCs in
NAc slices taken from naïve rats.
As we and others10,11,16,20 found that ZIP and scrambled ZIP
evoke similar outcomes, we speculated that the arginine residues
of ZIP themselves contribute to its function. We hypothesized
that ZIP binds to the synaptic membrane with the myristoyl
group which, following cleavage by peptidases, release free argi-
nine residues thereby increasing the arginine concentration local
to the AMPA receptor at the synaptic membrane. Although
neurons contain a large amount of intracellular free arginine, they
have the capacity to respond to exogenously applied arginine to
mediated NO effects, a phenomenon known as “The arginine
paradox”21. Previous studies have shown that extracellular argi-
nine binds to cell surface receptors activating NOS via G-
proteins22. Indeed, we found that arginine by itself decreased
AMPAR-EPSCs in NAc slices, similar to ZIP. However, we also
demonstrated that FITC-tagged peptide cleavage occurred intra-
cellularly and that inhibition of NOS by L-NAME blocked the
peptide-induced redistribution of AMPAR-GluA1. Furthermore,
intracellular application of L-NAME (via the patch pipette)
abrogated the Peptide B (arginine–alanine)-induced reduction in
AMPAR-mediated EPSCs in the NAc slices, similarly to ZIP.
Although we did not directly measure the intracellular con-
centration of arginine following peptide application, our results
support an effect mediated locally by intracellular arginine. These
results are in line with previous studies demonstrating the effect
of arginine/NO pathway in regulation of glutamate receptor
function17,23,24.
It has been well documented that AMPAR-GluA1 phosphor-
ylation results in its stabilization, increased conductance and
surface expression25. In response to NMDA-mediated calcium
influx, CaMKII is activated and phosphorylates AMPAR-GluA1
at S831, resulting in increased surface expression and stabiliza-
tion, underlying early phase LTP. However, among the processes
which regulate the phosphorylation of the AMPAR is NO-
signaling26,27, but the specific mechanisms underlying this NO-
mediated regulation are only now becoming clear. S-nitrosylation
of GluA1 at residue C875 was recently identified as an additional
route of AMPAR subunit modification, promoting phosphor-
ylation at the same GluA1-S831 residue. This resulted in sub-
sequent AMPA receptor endocytosis in cortical neurons, thereby
regulating synaptic plasticity17. Our results indicate that ZIP may
act as an arginine donor, hypothesizing that it bypasses the
NMDAR and downregulates GluA1 by this pathway. Indeed,
we show that the NOS inhibitor L-NAME could block the
Fig. 5 ZIP induces S-nitrosylation of GluA1 and increases phosphorylation of S831, and peptide B or scrambled ZIP attenuated the expression of
cocaine-conditioned reward. a Representative fluorescent images of fixed HEK293 cells expressing GFP-GluA1 (upper images), nitrosylation site mutant
GluA1-C875S (middle images) or phosphorylation site mutant GluA1-S831A (lower images), incubated for 40min with vehicle, ZIP or peptide B. Graphs
depict line scans of GFP signal intensity mean ± SEM (Upper: WT-GluA1, ZIP n= 10, Peptide B n= 10, vehicle: n= 7). Data analyzed by one-way ANOVA
(F= 10.27, p= 0.0006); Tukey post hoc test for multiple comparison show vehicle vs. ZIP *p= 0.0005, vehicle vs. Peptide B #p= 0.0061; Middle: GluA1-
C875S, vehicle n= 10, ZIP n= 12, Peptide B n= 10; n.s. no significant difference (F= 2.443, p= 0.1046, one-way ANOVA); Lower: GluA1-S831A, vehicle:
n= 13, ZIP n= 11, Peptide B n= 12; no significant difference was observed between groups, F= 0.4282, p= 0.6552, one-way ANOVA). b Western-blot
analysis of NAc slice-homogenates incubated prior to the homogenization for 30min with control vehicle, ZIP or scrZIP (5 μM). Blots were stained with
antibodies to GluA1-pS831, total GluA1 and tubulin. Graph indicates the mean change in phosphorylation relative to vehicle-treated (±SEM, vehicle N= 6,
ZIP N= 4, scrZIP N= 3; F= 18.04, p= 0.0005, one-way ANOVA followed by Tukey post hoc test shows significant differences vehicle vs. ZIP *p= 0.001,
vehicle vs. scrZIP **p= 0.0023). c Effect of peptide B or scrambled ZIP on CPP. Rats were habituated and conditioned to cocaine as described in methods.
One day after the conditioning period, rats were microinjected bilaterally into the NAc with peptide B (20 μg per side; N= 9), peptide C (20 μg per side;
N= 7), scrZIP (20 μg per side; N= 8) or vehicle (1 μl per side; N= 11) and one day later, tested for CPP. The bar histogram depicts the CPP score mean ±
SEM (as described in “Methods”). Two-way ANOVA (F= 7.110, p= 0.0003 for interaction) followed by Sidak’s test for multiple comparison within
Habituation data (n.s) and test data (vehicle vs. Peptide B *p= 0.0196, vehicle vs. Peptide C p > 0.9999 n.s., vehicle vs. scrZIP ***p= 0.0007, Peptide B vs.
Peptide C *p= 0.0327, Peptide B vs. scrZIP p= 0.8571 n.s., Peptide C vs. scrZIP **p= 0.0018).
AMPAR
Arg
L-NAME
Peptidase
NOS NO
SNO
C875
C875
GluA1
S831
Endocytosis
S831
P
ZIP
Fig. 6 Model for the molecular mechanism of ZIP.Myristoylated ZIP binds
to the cell membrane and is digested by peptidases to produce free arginine
residues (red circles). Arginine is a substrate of nitric oxide synthase
(NOS), which generates nitric oxide (NO). NO in turn, nitrosylates the
cysteine residue on position 875 on the cytoplasmic tail of the AMPAR
GluA1 subunit, which induces serine phosphorylation of GluA1 on position
831. S831 phosphorylation leads to endocytosis of AMPARs and
subsequent functional downregulation.
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ZIP-dependent reduction in EPSCs in the NAc. We also show
that the ZIP-induced redistribution of GluA1 in HEK293 cells
was not observed for the C875S-mutated GluA1, or in S831A-
mutated GluA1. In addition, ZIP or scrZIP induced the phos-
phorylation of S831 on GluA1 in NAc slices that were treated
with ZIP. Most importantly, microinjection of the
arginine–alanine peptide B and scrZIP into the NAc following
cocaine CPP paradigm, significantly reduced the expression of
CPP as we previously reported for ZIP itself12, while the control
peptide C has no effect of the expression of CPP.
Recently several studies raised the possibility that ZIP can act
nonspecifically to disrupt normal function of the brain. It has
been reported that ZIP as well as its PKMζ-inactive analog,
scrZIP, induced a dose-dependent increase in spontaneous
activity of neurons in dissociated cultures of rat hippocampal
neurons and also caused excitotoxic cell death16. In the current
study we found that ZIP had no effect on membrane potential
during the first 50 min of bath application, whereas its inhibitory
effect on AMPAR-EPSCs was apparent. In line with our study, it
was shown that in anesthetized rats, ZIP profoundly reduced
spontaneous hippocampal local field potentials, comparable in
magnitude to infusions of lidocaine, but with a slower onset and
longer duration19. This suggests that ZIP has no effect on
membrane potential, at least not when it interferes with AMPAR
activity. Furthermore, we found that when ZIP was injected
in vivo to the NAc, at the same concentration used in previous
behavioral studies12, no effect on cell viability was observed 24 h
following injection. Therefore, we suggest that the effects of ZIP
shown here are not due to its potential toxicity.
Previous studies on PKMζ knockout mice10,11 showed that
scrambled ZIP was able to reverse LTP maintenance in hippocampal
slices11, consistent with other findings that showed partial reversal of
fear conditioning memory following scrambled ZIP infusion into the
amygdala20. In contrast, Shema et al.8 used scrambled ZIP as a
control peptide that did not alter memory in a condition taste
aversion paradigm. Indeed, multiple studies support and contradict
the role of scrambled ZIP as a control in memory studies28. Here, we
show that, in addition to peptide B and ZIP12, scrambled ZIP sig-
nificantly attenuated the expression of cocaine CPP compared with
vehicle-infused animals. These findings support our hypothesis that
ZIP, scrambled ZIP and peptide B serve as arginine donors and
suggest that vehicle is a more appropriate control when testing the
effect of ZIP on learning and memory.
In summary, we propose that the mechanism by which ZIP
interferes with memory involves the activation of a NO-signaling
pathway that downregulates AMPAR activity and thus leads to
long-term memory impairment.
Methods
Animals. The Institutional Animal Care Committee (IACUC) of the Hebrew
University (Jerusalem, Israel) approved all procedures. Sprague Dawley male rats
(Harlan (Envigo) Laboratories, Jerusalem, Israel), 20–35 days old were used for
electrophysiological experiments and for peptide microinjections. Pregnant C57Bl6
mice were used for primary neurons and bred in-house. Animals were housed at an
ambient temperature of 22 °C, 30–70% humidity and a 12-h light/dark cycle with
the lights on at 7:00 a.m. Food and water were provided ad libitum.
Peptides. ZIP: myr-SIYRRGARRWRKL-OH (GLBiochem, China). scrZIP: myr-
RLYRKRIWRSAGR-OH (GLBiochem, China), a 13 amino acid peptide composed
from the amino acids of ZIP arranged in a random sequence. FITC-ZIP: Fluorescein
isothiocyanate (FITC), a fluorescent marker attached to the side chain of extra LYS
amino acid that was inserted between myristic acid and first amino acid of ZIP
(GLBiochem, China). ZIP-FITC: FITC, attached to the side chain of LYS prior to
leucine. Custom-designed peptides: Peptide B: MYR-AAARRAARRARAA-OH
(GLBiochem, China), a 13 amino acid peptide containing the ZIP five arginine
residues in their original position, but all other amino acids replaced with alanine;
Peptide C: MYR-SVTRRGARRFRIH-OH (GLBiochem, China), a 13 amino acid
peptide containing the ZIP five arginine residues but the sites of peptidases were
destroyed by appropriate amino acid replacements. All peptides were dissolved in
phosphate buffer solution at desired concentrations. L-NAME: Sigma [N5751],
L-Arg HCL: National Biochemicals
Plasmid preparation. pRK plasmids encoding GFP-tagged GluA1 and GluA2
(both flip isoforms) were a gift from P.H. Seeburg (Max Planck Institute for
Medical Research, Heidelberg, Germany)29. GFP-tagged GluA1-C875S and GluA1-
S831A were prepared using Q5 Site-Directed Mutagenesis Kit (NEB) with fol-
lowing oligonucleotide pairs according to the manufacture recommendation
Forward (5′–3′) Reverse (5′-3′)
GluA1C875S ATCCATTCCCTCCATG
AGTCACAG
TGCATGGACTT
GGGGAAG
GluA1 S831A CCCACAGCAAGCCAT
CAATGAAG
ATCAAACAGAAA
CCCTTCATCC
Cell culture. Human Embryonic Kidney (HEK)293 cells were passaged weekly and
seeded in growth medium (DMEM (−) Calcium (−) Mg (BioInd); 10% fetal bovine
serum (HyClone), 1% alanine–glutamine (BioInd), 1% Penicillin–Streptomycin
(BioInd), 25 mM HEPES (BioInd)) 24 h before the experiment. HEK293 cells were
transfected with AMPARs GluA1, GluA2, GluA1-C875S and GluA1-S831A GFP-
tagged plasmids (as appropriate) using transfection reagent JetPrime. Primary
neurons were prepared from embryonic 14-day-old (E14) C57/BL6 mice. Cortices
were dissected, pooled and roughly chopped. Tissue was incubated in 0.25% trypsin/
EDTA, and triturated in DMEM containing 10% FBS. Cells were centrifuged
(1500g, 3 min), resuspended and immediately plated at a density of 2 × 105 cells/cm2
on poly-L-lysine/laminin precoated cover slips in Neurobasal growth medium
(Neurobasal medium [Gibco], 2% B27 serum free supplement [Thermo], 300 μM
glutamine [BioInd], 1% Streptomycin–Amphotericin B). Neurons were maintained
in 5% CO2 at 37 °C for 7 days prior the experiment30.
ZIP (5 µM), scrZIP (5 µM) or vehicle (PBS) were bath applied to culture medium.
The localization of the GFP-tagged AMPARs in HEK293 cells was monitored with
confocal fluorescent microscopy (FV10, Olympus; with Fluoview v4.2 software) over
the time period stated. Alternatively, after 40min of treatment, cells were fixed in 4%
paraformaldehyde solution for 10min at RT and GFP fluorescence quantified using
ImageJ 1.53. For paraformaldehyde-fixed primary neurons, localization of the AMPARs
was examined by immunostaining with antibody specific to extracellular domain of
GluA1 AMPAR subunit (GluA1-N355/1—Abcam [ab174785]), visualized by confocal
fluorescent microscopy (FV10, Olympus; with Fluoview v4.2 software) and quantified
as below.
Quantification of GluA1 redistribution in cells. Fluorescence intensity was
quantified by ImageJ 1.53 (NIH) using the “straight line” tool to manually mark the
cell diameter. Fluorescence was measured along the length and expressed as
arbitrary units per pixel (A.U.).
Western blot analysis. HEK293 cells were detached from the dishes in cold PBS
and homogenized in RIPA buffer (320 mM sucrose, 10 mM Tris–HCl (pH 7.4), 1
mM EDTA, 1 mM EGTA, protease inhibitor cocktail (Sigma, P8340), phosphatase
inhibitors 1 mM Na3VO4, 5 mM NaF). Rats were decapitated under isoflurane
anesthesia, brains removed and punches of NAc and PFC homogenized in RIPA
buffer. Crude homogenates were centrifuged for 10 min at 1000g in 4 °C to separate
cell nuclei and unbroken cells. Supernatants were collected and used immediately
or stored at −20 °C.
Proteins (20 µg) from brain and HEK293 cell homogenates were resolved by
10% sodium dodecyl sulphate polyacrylamide gel electrophoresis and transferred to
a nitrocellulose membrane. Membranes were incubated overnight at 4 °C with
appropriate primary antibodies (GluA1—Mercury [AB1504]; GluA1-pS831—
Mercury [04-823]; PKMζ—Mercury [07-264]; anti-PKCζ—Abcam [ab59364]; anti-
PKCζ-pThr403/410—Cell Signaling [9378]; anti-PKC-iota—Abcam [ab53878];
Actin—Abcam [ab8227]; Tubulin—Sigma [T9026]). Following washes in PBS-T
(containing 1% Tween 20), membranes were incubated with appropriate
horseradish peroxidase-conjugated secondary antibodies (75 min, RT). Antibody
binding was visualized by chemiluminescence (EC-EZL, Biological industries;
Clarity Western ECL substrate, BioRad), imaged using BioRad ChemiDoc XRS+
apparatus and quantified in BioRad ImageLab software V5.
Stereotaxic surgery and peptide microinjections. Prior to the surgery rats were
anesthetized with xylazine/ketamine mixture (0.15/0.85) injected IP in 1.1 ml/kg
dosage and with tramadol HCL 0.5% solution injected SC in 1.0 ml/kg dosage.
Microinjection needle (33 gauge) connected to a 10 µl syringe (Hamilton) was then
inserted directly to the NAc and 1 µL of FITC-ZIP, peptide B, peptide C or scrZIP
(20 µg prepared in sterile PBS) or PBS alone was injected with a microinjection
syringe pump controller (Quintessential Stereotaxic Injector, Stoelting). FITC-ZIP
injections were performed unilaterally in NAc shell (coordinates from bregma: AP:
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+1.60, ML: ±0.75; −6.00 mm ventral to the skull surface31. Following FITC-ZIP
injection, rats were set aside for different periods of time (6–24 h after injection),
FITC-ZIP expression and post-injection tissue damage were evaluated. Peptide B
injections performed bilaterally in NAc shell. Following injection of peptides, rats
were returned to the home cage and subjected to CPP experiments.
Conditioned place preference (CPP). The CPP paradigm is a standard pre-
clinical behavioral model used to study the rewarding or aversive effects of a
stimulus. The CPP apparatus includes two chambers of different design and
intermediate chamber between them. Animals were divided into experiment and
control groups. Following acclimatization, the animals were introduced into the
CPP apparatus for a habituation session. At this session, animals were placed in
the middle chamber for 5 min and then allowed to explore all chambers for 15
min and the time spent in each side was recorded. The least-preferred com-
partment for each subject was then assigned to be the drug-paired compartment
(biased). Place conditioning: rats received saline (1 ml/kg, IP) or cocaine (15 mg/
kg, IP) at alternate days for the next 8 days and placed in the corresponding
compartment for 15 min. The test session was arranged in the same way as the
habituation sessions (described above). The CPP score calculated for each ani-
mal is defined in percents as timereward chambertimesaline chambertimereward chamberþtimesaline chamber :
Slice preparation and electrophysiological recordings. Rats were decapitated
under isoflurane anesthesia and a brain block containing the NAc was rapidly
isolated. Coronal slices, 250 μm thick, were cut using a vibratome VT1000S (Leica,
Nussloch, Germany) in ice-cold low-calcium artificial cerebrospinal fluid solution
(aCSF) containing (in mM) 119 NaCl, 26 NaHCO3, 11 glucose, 2.5 KCl, 1
NaH2PO4, 2 MgCl2, and 0.5 CaCl2. Slices were transferred to a holding chamber
filled with high-calcium (2 mM CaCl2) aCSF solution at 28–30 °C. Slices were
allowed to recover for at least one hour before being placed in a recording chamber
under continuous flow (2 ml min−1) of the aCSF solution. All solutions were
saturated constantly with 95% O2 and 5% CO2 throughout the experiments32. NAc
medium spiny neurons were visualized using an upright microscope with infrared
illumination. Whole-cell currents were recorded in a voltage-clamp configuration
using a Multiclamp 700B amplifier (Axon Instruments, Foster City, CA) and
pClamp 10 acquisition software (Axon Instruments, Foster City, CA). Electrodes
pulled from glass capillaries (4-5 MΩ resistance) were filled with an internal
solution containing the following (in mM): 120 CsCH3SO3, 20 HEPES, 0.4 EGTA,
2.8 NaCl, 5 TEA-Cl, 2.5 Mg2-ATP, and 0.3 Na3GTP, pH range 7.2–7.4, osmolarity
range 275–285 mOsm/L. Recordings of AMPAR-EPSCs were performed at a
holding potential of −70 mV. Series and input resistance were monitored con-
tinuously with a 4 mV depolarizing step given before every recording sweep and
experiments began only after series resistance had stabilized for 5 min at least. Data
were discarded if series resistance changed by more than 10% during the recording
session. To evoke EPSCs, a bipolar stainless steel stimulating electrode were placed
3–4 mm lateral to the recording electrode and were used to stimulate afferent fibers
at a frequency of 0.1 Hz. Data were filtered at 2 kHz, digitized at 10 kHz and
collected online. Measurement of membrane potential during bath application of
ZIP (Fig. 1g) was performed using current clamp mode.
Statistical analysis. All data are presented as mean ± SEM. Electrophysiological
results were normalized to baseline or control state. The amplitude of evoked
currents and the value of resting membrane potential were calculated by measuring
the difference between the peak of the current/potential and the baseline current/
potential immediately before the stimulus artifact. The changes in evoked current
amplitudes and in resting membrane potential where normalized to the average of
the first 10 min. Sample traces shown in the figures represent an average of six
traces. For multiple comparisons between groups, one-way or two-way ANOVA
was applied as appropriate, followed by Tukey or Sidak post hoc tests (Graphpad
Prism v.8). Two-tailed Student’s unpaired t test was used for pairwise comparisons.
A probability of p < 0.05 was considered statistically significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data are provided with this paper. Further data and reagents are available on
request from the authors.
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